Hepcdac

Shubham Pharmaceuticals
Hepcdac

Product Code : 82

 

Product Description

HEPCDAC:

Its contains Drug / Molecule Daclatasvir.

HEPCDAC is generic version of DAKLINZA.

 

USAGE & DESCRIPTION :

HEPCDAC has used with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.

 

Brand Name

Hepcdac

International Brand Name

Daklinza

Active Ingredients

Daclastavir

Packing

1*28

Doses Form

Tablets (IN Plastic Bottle)

Strength

30 Mg & 60 Mg

Mfg By

Cipla Ltd

 

CLINICAL APPLICATIONS :

It inhibits the Hepatitis C Virus (HCV) nonstructural protein by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

 

STORAGE :

Store below 25°C.

 

Trade Information

  • Main Export Market(s)
  • Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia